Literature DB >> 24949833

Mechanism of SB431542 in inhibiting mouse embryonic stem cell differentiation.

Juan Du1, Yongyan Wu2, Zhiying Ai1, Xiaoyan Shi1, Linlin Chen1, Zekun Guo3.   

Abstract

SB431542 (SB) is an established small molecular inhibitor that specifically binds to the ATP binding domains of the activin receptor-like kinase receptors, ALK5, ALK4 and ALK7, and thus specifically inhibits Smad2/3 activation and blocks TGF-β signal transduction. SB maintains the undifferentiated state of mouse embryonic stem cells. However, the way of SB in maintaining the undifferentiated state of mouse embryonic stem cells remains unclear. Considering that SB could not maintain embryonic stem cells pluripotency when leukemia inhibitory factor was withdrawn, we sought to identify the mechanism of SB on pluripotent maintenance. Transcripts regulated by SB, including message RNAs and small non-coding RNAs were examined through microarray and deep-sequence experiments. After examination, Western blot analysis, and quantitative real-time PCR verification, we found that SB regulated the transcript expressions related to self-renewal and differentiation. SB mainly functioned by inhibiting differentiation. The key pluripotent factors expression were not significantly affected by SB, and intrinsic differentiation-related transcripts including fibroblast growth factor family members, were significantly down-regulated by SB. Moreover, SB could partially inhibit the retinoic acid response to neuronal differentiation of mouse embryonic stem cells.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Differentiation; SB431542; Smad2/3; Undifferentiated state

Mesh:

Substances:

Year:  2014        PMID: 24949833     DOI: 10.1016/j.cellsig.2014.06.002

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  11 in total

1.  Inhibition of transforming growth factor β (TGF-β) signaling can substitute for Oct4 protein in reprogramming and maintain pluripotency.

Authors:  Fangzhi Tan; Cheng Qian; Ke Tang; Saber Mohamed Abd-Allah; Naihe Jing
Journal:  J Biol Chem       Date:  2014-12-29       Impact factor: 5.157

Review 2.  Pluripotent Stem Cells as a Robust Source of Mesenchymal Stem Cells.

Authors:  Carlos D Luzzani; Santiago G Miriuka
Journal:  Stem Cell Rev Rep       Date:  2017-02       Impact factor: 5.739

3.  Inhibition of transforming growth factor β signaling promotes epiblast formation in mouse embryos.

Authors:  Sabitri Ghimire; Björn Heindryckx; Margot Van der Jeught; Jitesh Neupane; Thomas O'Leary; Sylvie Lierman; Winnok H De Vos; Susana Chuva de Sousa Lopes; Tom Deroo; Petra De Sutter
Journal:  Stem Cells Dev       Date:  2014-10-29       Impact factor: 3.272

4.  CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi Anemia.

Authors:  Mark Osborn; Cara-Lin Lonetree; Beau R Webber; Dharmeshkumar Patel; Samantha Dunmire; Amber N McElroy; Anthony P DeFeo; Margaret L MacMillan; John Wagner; Bruce R Balzar; Jakub Tolar
Journal:  Stem Cells Dev       Date:  2016-08-18       Impact factor: 3.272

5.  TGFβ signaling promotes matrix assembly during mechanosensitive embryonic salivary gland restoration.

Authors:  Sarah B Peters; Deirdre A Nelson; Hae Ryong Kwon; Matthew Koslow; Kara A DeSantis; Melinda Larsen
Journal:  Matrix Biol       Date:  2015-01-31       Impact factor: 11.583

6.  miR‑146b‑5p promotes the neural conversion of pluripotent stem cells by targeting Smad4.

Authors:  Nianping Zhang; Ying Lyu; Xuebing Pan; Liping Xu; Aiguo Xuan; Xiaosong He; Wandan Huang; Dahong Long
Journal:  Int J Mol Med       Date:  2017-07-11       Impact factor: 4.101

7.  Differences in the Activity of Endogenous Bone Morphogenetic Protein Signaling Impact on the Ability of Induced Pluripotent Stem Cells to Differentiate to Corneal Epithelial-Like Cells.

Authors:  Taty Anna Kamarudin; Sanja Bojic; Joseph Collin; Min Yu; Sameer Alharthi; Harley Buck; Alex Shortt; Lyle Armstrong; Francisco C Figueiredo; Majlinda Lako
Journal:  Stem Cells       Date:  2017-12-21       Impact factor: 6.277

8.  miR-24 and miR-122 Negatively Regulate the Transforming Growth Factor-β/Smad Signaling Pathway in Skeletal Muscle Fibrosis.

Authors:  Yaying Sun; Hui Wang; Yan Li; Shaohua Liu; Jiwu Chen; Hao Ying
Journal:  Mol Ther Nucleic Acids       Date:  2018-04-22       Impact factor: 8.886

9.  Role of the Hippo signaling pathway in safflower yellow pigment treatment of paraquat-induced pulmonary fibrosis.

Authors:  Hai Li; Baotian Kan; Lingli Song; Yufa Liu; Xiangdong Jian
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

10.  Reactive Oxygen Species and p38MAPK Have a Role in the Smad2 Linker Region Phosphorylation Induced by TGF-β.

Authors:  Reyhaneh Niayesh Mehr; Alireza Kheirollah; Faezeh Seif; Parisa Dayati; Hossein Babaahmadi-Rezaei
Journal:  Iran J Med Sci       Date:  2018-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.